RTW INVESTMENTS, LP bought 1,200,000 shares of Orchestra BioMed Holdings, Inc. at $5.00 for $6.00M on Nov 9, 2026

Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
10% owner
10%
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$6,000,000Shares × reported price
Shares traded
1,200,000Common Stock
Price per share
$5.00Reported price. Read footnotes for ranges.
% of reported position traded
12.56%This security and ownership context
Holdings after
10,756,063Indirect · See footnote
Trade date
Nov 9, 2026Buy
Filed
Nov 12, 2026, 4:27 PM ET3-day reporting delay
Accession
0001231919-26-001568Code P · Transaction 398994
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 9,556,063 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

OBIO price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
OBIO · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −3.3%1w ago −3.9%1d ago −7.6%
Returns since7d30d90d180d1y

Footnotes in full

F1: Held by certain affiliated funds (the "RTW Funds") managed by RTW Investments, LP ("RTW"). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their respective pecuniary interests therein.